Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Heron Therapeutics, Inc. (HRTX)

Pharmaceutical Preparations

https://www.herontx.com

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

4242 CAMPUS POINT COURT, SUITE 200
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/27/1987

Market Cap

290,444,220

Shares Outstanding

150,070,000

Weighted SO

150,072,640

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

MREO --.--%

TERN --.--%

PDSB --.--%

INZY --.--%

HOOK --.--%

XFOR --.--%

ABOS --.--%

DAWN --.--%

ELDN --.--%

Beta

1.8070

Last Div

0.0000

Range

0.5-3.93

Chg

-0.0350

Avg Vol

2547759

Mkt Cap

290444220

Exch

NASDAQ

Country

US

Phone

858 251 4400

DCF Diff

1.0095

DCF

3.7995

Div Yield

0.0000

P/S

2.1300

EV Multiple

-10.3340

P/FV

-7.6875

Div Yield %

0.0000

P/E

-6.0603

PEG

-29.2607

Payout

0.0000

Current Ratio

2.3802

Quick Ratio

1.8465

Cash Ratio

0.2289

DSO

197.2956

DIO

332.4909

Op Cycle

529.7865

DPO

79.3219

CCC

450.4646

Gross Margin

0.6549

Op Margin

-0.3402

Pretax Margin

-0.3529

Net Margin

-0.3529

Eff Tax Rate

-0.0355

ROA

-0.2206

ROE

1.4424

ROCE

-0.3366

NI/EBT

1.0000

EBT/EBIT

1.0374

EBIT/Rev

-0.3402

Debt Ratio

0.8134

D/E

-4.6764

LT Debt/Cap

1.2784

Total Debt/Cap

1.2720

Int Coverage

-16.9872

CF/Debt

-0.1175

Equity Multi

-5.7495

Rec Turnover

1.8500

Pay Turnover

4.6015

Inv Turnover

1.0978

FA Turnover

6.8051

Asset Turnover

0.6251

OCF/Share

-0.1369

FCF/Share

-0.1479

Cash/Share

0.4422

OCF/Sales

-0.1529

FCF/OCF

1.0806

CF Coverage

-0.1175

ST Coverage

-6.5260

CapEx Coverage

-12.4071

Div&CapEx Cov

-12.4071

P/BV

-7.6875

P/B

-7.6875

P/S

2.1300

P/E

-6.0603

P/FCF

-12.8949

P/OCF

-13.9927

P/CF

-13.9927

PEG

-29.2607

P/S

2.1300

EV Multiple

-10.3340

P/FV

-7.6875

DPS

0.0000

Latest Headlines (EST)

PennyStocks Nov 24, 11:48 4 Penny Stocks To Watch Under $5; Are They A Buy Now? PennyStocks Nov 24, 11:48 4 Penny Stocks To Watch Under $5; Are They A Buy Now? PennyStocks Nov 20, 14:03 Which Penny Stocks Are Best? 3 That Insiders Like In November PennyStocks Nov 20, 14:03 Which Penny Stocks Are Best? 3 That Insiders Like In November PennyStocks Nov 17, 11:19 Penny Stocks To Buy? 4 Under $5 To Watch Right Now Benzinga Nov 15, 14:30 Why Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today? Zacks Investment Research Nov 14, 18:00 Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks Investment Research Nov 14, 18:00 Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks Investment Research Nov 14, 18:00 Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks Investment Research Nov 14, 18:00 Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Revenue Product Segmentation